1402 - Sigmapharm Laboratories
Alternative Names: ΣΦ-1402Latest Information Update: 28 Jun 2024
At a glance
- Originator Sigmapharm Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for research development in Unspecified in USA
- 05 Oct 2018 Early research in Unspecified in USA (unspecified route) (Sigmapharm Laboratories pipeline, November 2022)